Phase I study of domatinostat (4 SC ‐202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
Year: 2019
Type: article
Study design: Clinical Trial
Source: European Journal Of Haematology
DOI: 10.1111/ejh.13188
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Robert Bosch Stiftung
OpenAlex ID: W2896604147
